Literature DB >> 9352763

Acute weakness syndromes in critically ill patients--a reappraisal.

J L Nates1, D J Cooper, B Day, D V Tuxen.   

Abstract

Over the last twenty years, increasing numbers of critically ill, mechanically ventilated patients who develop acute profound muscle weakness have been described. These acute weakness syndromes have not been well understood and they have been given many names including: acute steroid myopathy, acute quadriplegic myopathy, the floppy person syndrome, critical illness polyneuropathy, critical illness polyneuromyopathy, and prolonged neurogenic weakness. Many of these "syndromes" either overlap or represent the same disease process in different patients. Many have been incompletely diagnosed. During this review it became evident that the acute weakness syndromes currently recognized in critically ill patients could be categorized into four major groups: myopathy, neuromuscular junction abnormalities, neuropathy and polyneuromyopathy. Each had different possible aetiologies. "Myopathy" includes acute necrotizing myopathy and disuse atrophy. Neuromuscular junction abnormalities are subdivided into myasthenia-like syndromes and prolonged neuromuscular blockade. Neuropathies are divided into critical illness polyneuropathy and acute motor neuropathy. The anterior horn cell injury in Hopkins syndrome should also be considered in this group. Polyneuromyopathies include various combinations of neuropathy and myopathy in the same patients.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9352763     DOI: 10.1177/0310057X9702500509

Source DB:  PubMed          Journal:  Anaesth Intensive Care        ISSN: 0310-057X            Impact factor:   1.669


  6 in total

Review 1.  Management of intracranial hypertension.

Authors:  Leonardo Rangel-Castilla; Leonardo Rangel-Castillo; Shankar Gopinath; Claudia S Robertson
Journal:  Neurol Clin       Date:  2008-05       Impact factor: 3.806

2.  Severe weakness complicating status asthmaticus despite minimal duration of neuromuscular paralysis.

Authors:  Sarah M Kesler; Mark D Sprenkle; William S David; James W Leatherman
Journal:  Intensive Care Med       Date:  2008-09-20       Impact factor: 17.440

3.  [Critical illness polyneuropathy und polymyopathy. How certain is the clinical diagnosis in patients with weaning failure?].

Authors:  F Oehmichen; M Pohl; R Schlosser; D Stogowski; D Toppel; J Mehrholz
Journal:  Nervenarzt       Date:  2012-02       Impact factor: 1.214

4.  Preferential skeletal muscle myosin loss in response to mechanical silencing in a novel rat intensive care unit model: underlying mechanisms.

Authors:  Julien Ochala; Ann-Marie Gustafson; Monica Llano Diez; Guillaume Renaud; Meishan Li; Sudhakar Aare; Rizwan Qaisar; Varuna C Banduseela; Yvette Hedström; Xiaorui Tang; Barry Dworkin; G Charles Ford; K Sreekumaran Nair; Sue Perera; Mathias Gautel; Lars Larsson
Journal:  J Physiol       Date:  2011-02-14       Impact factor: 5.182

5.  Role of endotoxin in the pathogenesis of critical illness polyneuropathy.

Authors:  B Mohammadi; I Schedel; K Graf; A Teiwes; H Hecker; B Haameijer; D Scheinichen; S Piepenbrock; R Dengler; J Bufler
Journal:  J Neurol       Date:  2008-02-20       Impact factor: 4.849

6.  Combination of histopathological and electromyographic patterns can help to evaluate functional outcome of critical ill patients with neuromuscular weakness syndromes.

Authors:  François Kerbaul; Muriel Brousse; Frédéric Collart; Jean-François Pellissier; Denis Planche; Carla Fernandez; François Gouin; Catherine Guidon
Journal:  Crit Care       Date:  2004-09-10       Impact factor: 9.097

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.